Concepedia
Statistics
Publications
5
Citations
186
H-Index
Active since
1997
Affiliations
Pfizer (United States)(Current)
University of Southern California
John W. Grunden is an author at Pfizer (United States) specializing in ophthalmology, medicine, and clinical trials.
Top concepts
MedicineEye TrackingHypertensionOphthalmologyAnesthesiologyClinical Trials
Publications per year
1997–2010
Lovastatin-Induced Rhabdomyolysis Possibly Associated with Clarithromycin and Azithromycin
John W. Grunden, Karen A. Fisher · Annals of Pharmacotherapy · 1997 · 73 citations
Assessing the Importance of IOP Variables in Glaucoma Using a Modified Delphi Process
Paul P. Lee, Marla B. Sultan, John W. Grunden et al. · Journal of Glaucoma · 2010 · 36 citations
Inter-visit Intraocular Pressure Range: An Alternative Parameter for Assessing Intraocular Pressure Control in Clinical Trials
Rohit Varma, Lie‐Ju Hwang, John W. Grunden et al. · American Journal of Ophthalmology · 2008 · 32 citations
Alternative Parameter, Hypertension, Ophthalmology +9
Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy
Rohit Varma, L-J Hwang, John W. Grunden et al. · British Journal of Ophthalmology · 2009 · 25 citations
Five-year, Multicenter Safety Study of Fixed-combination Latanoprost/Timolol (Xalacom) for Open-angle Glaucoma and Ocular Hypertension
Albert Alm, John W. Grunden, Kenneth Kwok · Journal of Glaucoma · 2010 · 20 citations
1–5 of 5